RBC Europe’s Kite Pharma, Inc. KITE Stock Holding History

RBC Europe’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100	Closed	-$18K	–	1176
2017 Q3	$18K	Buy	+100	New	+$13.9K	﹤0.01%	706

RBC Europe's KITE Position: Q4 2017 in Review

RBC Europe sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 100 shares — an estimated $18K sold.

RBC Europe first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $18K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

RBC Europe reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
RBC Europe sold 100 Kite Pharma, Inc. shares in Q4 2017, an estimated $18K.
RBC Europe first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
RBC Europe's Kite Pharma, Inc. position peaked at $18K in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on RBC Europe's 13F filing for Q4 2017, filed 9 Nov 2023.